Literature DB >> 30817818

Compensatory Hippocampal Connectivity in Young Adults With Early-Stage Type 2 Diabetes.

Fang Fang1, Meng-Yu Lai1, Jing-Jing Huang1, Mei Kang2, Ming-Ming Ma3, Kang-An Li4, Jing-Ge Lian4, Zheng Wang5, Da-Zhi Yin5, Yu-Fan Wang1.   

Abstract

CONTEXT: Middle-aged to elderly patients with type 2 diabetes mellitus (T2DM) exhibit reduced functional connectivity and brain atrophy underlying cognitive decrements; however, little is known about brain abnormalities in young patients.
OBJECTIVE: To detect brain anatomical and functional changes in young patients with T2DM during the early disease stage.
DESIGN: Case-control study.
SETTING: Tertiary referral hospital. PARTICIPANTS: Thirty-five young patients with T2DM (<40 years of age) with no detectable microangiopathy and 32 nondiabetic control subjects. INTERVENTION: None. MAIN OUTCOME MEASURES: Subjects underwent neuropsychological assessments and structural and resting-state functional MRI. Both voxel-based morphometry and resting-state functional connectivity analyses were performed.
RESULTS: No significant differences in brain volume were observed between the patients with T2DM and the controls after controlling for age, sex, education, and body mass index. Compared with the controls, the patients showed greater connectivity of the left hippocampus with the left inferior frontal gyrus and the left inferior parietal lobule. Moreover, the enhanced functional connectivity of left hippocampus with the left inferior frontal gyrus significantly correlated with disease severity (urinary albumin-to-creatinine ratio) (r = 0.613, P < 0.001) and executive function (completion time of Stroop Color and Word Test) (r = -0.461, P = 0.005) after false discovery rate correction.
CONCLUSIONS: Our findings suggest an adaptive compensation of brain function to counteract the insidious cognitive decrements during the early stage of T2DM. Additionally, the functional alterations occurring before changes in brain structure and peripheral microangiopathy might serve as early biomarkers related to cognitive decrements.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Year:  2019        PMID: 30817818     DOI: 10.1210/jc.2018-02319

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Cognitive Dysfunction in Type 2 Diabetes Is Not a One-Way Process: Evidence From a Longitudinal Brain Connectivity Study.

Authors:  Fang Fang; Yu-Jia Gong; Qian Luo; Ren-Bin Ge; Mei Kang; Ming-Ming Ma; Lei Zhang; Di Mu; Da-Zhi Yin; Yu-Fan Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

2.  Altered Hippocampal Subfields Volumes Is Associated With Memory Function in Type 2 Diabetes Mellitus.

Authors:  Mingrui Li; Yifan Li; Yujie Liu; Haoming Huang; Xi Leng; Yuna Chen; Yue Feng; Xiaomeng Ma; Xin Tan; Yi Liang; Shijun Qiu
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

3.  Large-scale functional connectivity predicts cognitive impairment related to type 2 diabetes mellitus.

Authors:  An-Ping Shi; Ying Yu; Bo Hu; Yu-Ting Li; Wen Wang; Guang-Bin Cui
Journal:  World J Diabetes       Date:  2022-02-15

4.  Changes of brain function in patients with type 2 diabetes mellitus measured by different analysis methods: A new coordinate-based meta-analysis of neuroimaging.

Authors:  Ze-Yang Li; Teng Ma; Ying Yu; Bo Hu; Yu Han; Hao Xie; Min-Hua Ni; Zhu-Hong Chen; Yang-Ming Zhang; Yu-Xiang Huang; Wen-Hua Li; Wen Wang; Lin-Feng Yan; Guang-Bin Cui
Journal:  Front Neurol       Date:  2022-08-24       Impact factor: 4.086

5.  Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis.

Authors:  Tianqi Zhang; Marnie Shaw; Nicolas Cherbuin
Journal:  Diabetes Metab J       Date:  2022-03-08       Impact factor: 5.893

6.  Atrophy patterns of hippocampal subfields in T2DM patients with cognitive impairment.

Authors:  MengChun Li; LiLi Huang; Dan Yang; CaiMei Luo; RuoMeng Qin; Bing Zhang; Hui Zhao; Yun Xu
Journal:  Endocrine       Date:  2020-03-14       Impact factor: 3.633

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.